Superti-Furga A, Hästbacka J, Wilcox WR, et al. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet. 1996;12(1):100-2. doi:10.1038/ng0196-100
Reich DE, Schaffner SF, Daly MJ, et al. Human genome sequence variation and the influence of gene history, mutation and recombination. Nat Genet. 2002;32(1):135-42. doi:10.1038/ng947
Nau GJ, Richmond JFL, Schlesinger A, Jennings EG, Lander ES, Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A. 2002;99(3):1503-8. doi:10.1073/pnas.022649799
Dolgin E. Massive schizophrenia genomics study offers new drug directions. Nat Rev Drug Discov. 2014;13(9):641-2. doi:10.1038/nrd4411
Ahola-Olli AV, Würtz P, Havulinna AS, et al. Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors. Am J Hum Genet. 2017;100(1):40-50. doi:10.1016/j.ajhg.2016.11.007
Bhatt S, Gupta MK, Khamaisi M, et al. Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes. Cell Metab. 2015;22(2):239-52. doi:10.1016/j.cmet.2015.07.015
Andreadis A, Wagner BK, Broderick JA, Kosik KS. A tau promoter region without neuronal specificity. J Neurochem. 1996;66(6):2257-63.
Chen I, Dorr BM, Liu DR. A general strategy for the evolution of bond-forming enzymes using yeast display. Proc Natl Acad Sci U S A. 2011;108(28):11399-404. doi:10.1073/pnas.1101046108
Schreiber SL. Stuart Schreiber: biology from a chemist’s perspective. Interview by Joanna Owens. Drug Discov Today. 2004;9(7):299-303. doi:10.1016/S1359-6446(04)03063-6